Related Experiment Video
Updated: Aug 8, 2025

Author Spotlight: Insight Into Advances in Prion Diseases Research
Published on: August 11, 2023
Mesenchymal stem cell-derived neural progenitors attenuate proinflammatory microglial activation via paracrine
Violaine K Harris1, Derek Bishop1, Jaina Wollowitz1
1Tisch Multiple Sclerosis Research Center of New York, NY 10019, USA.
Abstract:
Background: Mesenchymal stem cell-derived neural progenitor cell (MSC-NP) therapy is an experimental approach to treat multiple sclerosis. The influence of MSC-NPs on microglial activation was investigated. Methods: Microglia were stimulated in the presence of MSC-NP-conditioned media, and proinflammatory or proregenerative marker expression was assessed by quantitative PCR and ELISA. Results: Microglia stimulated in the presence of MSC-NP-conditioned media displayed reduced expression of proinflammatory markers including CCL2, increased expression of proregenerative markers and reduced phagocytic activity. The paracrine effects of MSC-NPs from multiple donors correlated with TGF-β3 gene expression and was reversed by TGF-β signaling inhibition. Conclusion: MSC-NPs promote beneficial microglial polarization through secreted factors. This study suggests that microglia are a potential therapeutic target of MSC-NP cell therapy.
Insights
Mesenchymal stem cell-derived neural progenitor cells (MSC-NPs) modulate microglia towards a beneficial state. This suggests MSC-NP therapy may target microglia for multiple sclerosis treatment.
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Multiple sclerosis (MS) is a neuroinflammatory disease.
- Mesenchymal stem cell-derived neural progenitor cell (MSC-NP) therapy is being explored for MS.
- The impact of MSC-NPs on microglia, key immune cells in MS, is under investigation.
Purpose of the Study:
- To investigate the influence of MSC-NPs on microglial activation.
- To determine if MSC-NPs can modulate microglial polarization towards a proregenerative phenotype.
Main Methods:
- Microglia were stimulated with MSC-NP-conditioned media.
- Quantitative PCR and ELISA were used to assess gene and protein expression.
- Proinflammatory and proregenerative markers, as well as phagocytic activity, were measured.
Main Results:
- MSC-NP conditioned media reduced proinflammatory markers (e.g., CCL2) and increased proregenerative markers in microglia.
- Phagocytic activity of microglia was reduced.
- These paracrine effects correlated with TGF-β3 expression and were blocked by TGF-β signaling inhibition.
Conclusions:
- MSC-NPs promote a beneficial microglial polarization via secreted factors.
- Microglia represent a potential therapeutic target for MSC-NP cell therapy in MS.
Related Concept Videos
Mesenchymal Stem Cells
Differentiation of Common Myeloid Progenitor Cells

